CIRCB Celebrates 20 Years of Biomedical Research in Cameroon

The Chantal Biya International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB) was inaugurated in 2006 and has since become a prominent biomedical research and public health hub in Cameroon and Central Africa. Under the supervision of the Ministry of Public Health, CIRCB has carried out its mission of conducting multidisciplinary research, clinical trials, and public health training focused on HIV/AIDS prevention and care.

Over the past 20 years, CIRCB has expanded from a specialized HIV facility into a comprehensive center for infectious disease control, clinical care, and scientific training. The center has eight specialized laboratories for molecular biology, vaccinology, immunology, and virology, which evaluate candidate vaccines and study HIV-related coinfections such as tuberculosis, viral hepatitis, and malaria.

CIRCB provides outpatient consultations, biomedical analyses, and early infant diagnosis to thousands of patients annually, operating as a public administrative establishment with hospital status. The center also offers technical and laboratory support to the Ministry of Public Health and the National AIDS Control Committee. Its activities have contributed to a considerable reduction in Cameroon's national HIV prevalence from 3.4 percent to 2.6 percent over recent years.

During the COVID-19 pandemic and other viral outbreaks, CIRCB mobilized its molecular biology platforms to support national diagnostic testing and genomic surveillance. The facility also carries out preventive education programs in the ten regions of the country, promoting HIV/STI awareness and voluntary testing among students and teachers.

CIRCB regularly hosts international conferences and training sessions, further solidifying its position as a leading research center in the region. The center's work has not only improved healthcare outcomes in Cameroon but also contributed to the global understanding of HIV/AIDS and other infectious diseases.

The Ministry of Public Health and other stakeholders have acknowledged CIRCB's significant contributions to the country's healthcare system. As the center celebrates 20 years of service, it continues to play a vital role in shaping the future of biomedical research and public health in Cameroon and beyond.

Looking ahead, CIRCB is expected to continue its critical work in infectious disease control and research, addressing emerging health challenges and building on its legacy as a premier research institution in Central Africa. The center's ongoing efforts will likely have a lasting impact on the health and well-being of communities in the region.

Key points

• CIRCB has contributed to a reduction in Cameroon's national HIV prevalence from 3.4 percent to 2.6 percent over recent years.